The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ANCA-Associated Vasculitis in Systemic Sclerosis

ANCA-Associated Vasculitis in Systemic Sclerosis

October 1, 2014 • By Carmen Busca Arenzana, MR, Ander Mayor-Ibarguren, MR, Amara Pieren-Salazar, MR, Natalia Martin-Suñe, MD, Isabel Esteban-Rodríguez, MD, Juan José Ríos-Blanco, MD, & Francisco Arnalich-Fernández, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

She improved progressively and currently has no peripheral neuropathy or myopathy. Her pulmonary involvement has been stable. However, over time, there has been more extensive cutaneous sclerosis and the development of more digital ulcers.

You Might Also Like
  • Diagnostic Criteria, Classification Lacking for Vasculitis; New Research in Treatment for Systemic Sclerosis
  • Systemic Sclerosis Mortality Rate May Be Underestimated
  • Dermatology Case: History of ANCA–Associated Vasculitis, Fever, Rash
Explore This Issue
October 2014

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
A large, well-demarcated ulcer along the medial malleolar area is shown in a patient with systemic sclerosis. Such ulcers are associated with small-vessel vasculitis.
A large, well-demarcated ulcer along the medial malleolar area is shown in a patient with systemic sclerosis. Such ulcers are associated with small-vessel vasculitis.

Discussion

The development of vasculitis in patients with SS is highly uncommon.1 Whereas the histopathology of SS vasculopathy demonstrates a myofibroblast proliferation and matrix deposition in the subendothelial layer leading to occlusion, the histopathology of vasculitis is characterized by the presence of mononuclear infiltrates and destruction of the vessel wall.

A recent publication by the French Vasculitis Study Group identified nine patients with SS and vasculitis.2 Another study described the characteristics of a series of 40 patients with SS and associated systemic vasculitis, finding that the main clinical manifestation was a rapidly progressive glomerulonephritis (83%), followed by alveolar hemorrhage (28%), limb ischemia (13%) and skin vasculitis (10%).3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The presence of a positive ANCA in patients with SS is estimated to be in the range of 7–13%, but its clinical relevance is unknown. MPO-ANCA is more frequent than PR3-ANCA in patients with SS.4

Conclusion

The patient improved after immunosuppressive therapy. She has not experienced a new outbreak of vasculitis, although her cutaneous disease related to scleroderma has progressed.


Carmen Busca Arenzana is a medical resident in the internal medicine department of the Hospital La Paz in Madrid, Spain.
Ander Mayor-Ibarguren is a medical resident in the dermatology department of the Hospital La Paz in Madrid, Spain.
Amara Pieren-Salazar is a medical resident in the rheumatology department of the Hospital La Paz in Madrid, Spain.
Natalia Martin-Suñe, MD, works in the internal medicine department of the Hospital La Paz in Madrid, Spain.
Isabel Esteban-Rodríguez, MD, works in the pathology department of the Hospital La Paz in Madrid. Spain.
Juan José Ríos-Blanco, MD, works in the internal medicine department of the Hospital La Paz in Madrid, Spain.
Francisco Arnalich-Fernandez, MD, works in the internal medicine department of the Hospital La Paz in Madrid, Spain.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Quéméneur T, Mouthon L, Cacoub P, et al. Systemic vasculitis during the course of systemic sclerosis. Medicine (Baltimore). 2013 Jan;92(1):1–9.
  2. Arad U, Balbir-Gurman A, Doenyas-Barak K, et al. Anti-neutrophil associated vasculitis in systemic sclerosis. Semin Arthritis Rheum. 2011 Oct;41(2):223–229.
  3. Rho YH, Choi SJ, Lee YH, et al. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int. 2006 Mar;26(5):369–375.
  4. Mouthon L, Millet A, Régent A, et al. Physiopathologie des vascularites ANCA-positives. Presse Med. 2012 Oct;41(10):996–1003.

Acknowledgments: The authors would like to thank Martin J. Smyth for his help in correcting their English.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Scleroderma Tagged With: ANCA vasculitis, drug, patient care, peripheral nerve disease, prednisone, Raynaud's, rheumatologist, Scleroderma, Systemic sclerosis, Treatment, VasculitisIssue: October 2014

You Might Also Like:
  • Diagnostic Criteria, Classification Lacking for Vasculitis; New Research in Treatment for Systemic Sclerosis
  • Systemic Sclerosis Mortality Rate May Be Underestimated
  • Dermatology Case: History of ANCA–Associated Vasculitis, Fever, Rash
  • Fellow’s Forum Case Report: Limited Cutaneous Systemic Sclerosis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)